Update on hormone replacement therapy

Area of Science:

• Endocrinology
• Women's Health
• Pharmacology

Background:

• Hormone replacement therapy (HRT) is widely recognized for its benefits in managing menopausal symptoms and preventing associated health issues.
• Key benefits include relief from vasomotor symptoms, psychogenic manifestations, and atrophic vaginitis.
• HRT also plays a role in osteoporosis prevention and treatment, and potentially in cardiovascular disease prevention.

Purpose of the Study:

• To review the established benefits of hormone replacement therapy (HRT).
• To discuss the risks associated with HRT and strategies for minimization.
• To examine the impact of combined estrogen and progestogen therapy on lipid levels, endometrial cancer, and breast cancer risk.

Main Methods:

• Literature review of studies on hormone replacement therapy.
• Analysis of data regarding the effects of estrogen and progestogen on physiological markers.
• Examination of epidemiological data on cancer incidence and prognosis in HRT users.

Main Results:

• HRT effectively alleviates menopausal symptoms and prevents conditions like osteoporosis and atrophic vaginitis.
• Risks associated with HRT can be minimized through careful patient evaluation and appropriate hormone selection.
• Combined estrogen and progestogen therapy does not adversely affect lipid levels and reduces endometrial cancer incidence.
• The risk of breast cancer with HRT is debated, but estrogen therapy alone does not appear to increase it, and progestogen may offer protection for some women.

Conclusions:

• Hormone replacement therapy provides substantial benefits for postmenopausal women when managed appropriately.
• Combined hormone therapy is associated with a reduced risk of endometrial cancer and potentially breast cancer.
• HRT may improve the prognosis for women diagnosed with breast cancer.